Pharmaceutical composition for treating influenza virus containing the quinazoline derivatives

The present invention relates to a pharmaceutical composition for treating influenza virus infection containing a quinazoline derivative. According to the present invention, the quinazoline derivative which is represented by chemical formula 1 shows low toxicity to normal cells and outstanding antiv...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, MEE HYEIN, JANG, YE JIN, CHO, WON JEA, GO, YUN YOUNG, SHIN, JIN SOO
Format Patent
LanguageEnglish
Korean
Published 08.12.2017
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a pharmaceutical composition for treating influenza virus infection containing a quinazoline derivative. According to the present invention, the quinazoline derivative which is represented by chemical formula 1 shows low toxicity to normal cells and outstanding antiviral activities against influenza virus, thereby being useful as pharmaceutical compositions for preventing or treating influenza virus infection. 본 발명은 퀴나졸린 유도체를 함유하는 인플루엔자 바이러스 치료용 약학적 조성물에 관한 것으로, 본 발명에 따른 화학식 1의 퀴나졸린 유도체는 정상세포에 대한 독성이 낮을 뿐만 아니라, 인플루엔자 바이러스에 대해 매우 우수한 항바이러스 활성을 가지므로, 인플루엔자 바이러스의 예방 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다.
Bibliography:Application Number: KR20160067322